Get the Stockscreener App
6.45
2.71%
-0.18
After Hours:
6.50
0.05
+0.78%
Aethlon Medical Inc stock is traded at $6.45, with a volume of 40,818.
It is down -2.71% in the last 24 hours and up +254.40% over the past month.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
See More
Previous Close:
$6.63
Open:
$6.54
24h Volume:
40,818
Relative Volume:
0.02
Market Cap:
$4.59M
Revenue:
$574.20K
Net Income/Loss:
$-7.15M
P/E Ratio:
-0.4062
EPS:
-15.8778
Net Cash Flow:
$-7.00M
1W Performance:
+2.71%
1M Performance:
+254.40%
6M Performance:
+204.25%
1Y Performance:
+706.96%
1-Day Range:
$6.3849
$6.69
1-Week Range:
$5.95
$6.69
52-Week Range:
$0.5079
$9.50
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
6.45 | 4.47M | 574.20K | -7.15M | -7.00M | -15.88 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Resumed | H.C. Wainwright | Neutral |
Aethlon Medical Inc Stock (AEMD) Latest News
Aethlon Medical shareholders approve equity plan amendments and board elections - Investing.com Canada
Form 8K Aethlon Medical Inc For: 1 October - Investing.com India
AEMD: All proposals except preferred stock authorization were approved, with no stockholder questions - TradingView
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
North Immunology, Aethlon Merge to Advance NOR-101 for AD - Dermatology Times
Are PRTH, MG, AEMD Obtaining Fair Deals for their Shareholders? - Times Argus
What Does Aethlon Medical (NASDAQ:AEMD) Reveal About Penny Stocks? - kalkinemedia.com
Law firm investigates fairness of Aethlon Medical's merger deal for shareholders. - Pluang
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD) - PR Newswire
Aethlon Stock Pulls Back: What's Going On? - Benzinga
Aethlon Medical shares fall 9% after surging 300% on North Immunology merger news - scanx.trade
Aethlon Medical stock merger with North Immunology, H.C. Wainwright holds neutral - Investing.com
Aethlon Medical stock merger with North Immunology, H.C. Wainwright holds neutral By Investing.com - Investing.com South Africa
Aethlon Medical Q1FY27 Results: Operating expenses fall 11.9% to $1.6 million - scanx.trade
Aethlon Medical Q1 2027 Earnings Call Transcript - Benzinga
US Stocks Today: Top Gainers and Losers on Sept 18 - HDFC Sky
AEMD, OKLO, DAIC, XENE, MRNA: 5 Trending Stocks TodayModerna (NASDAQ:MRNA) - Benzinga
Aethlon Medical Shares Surge Over 470% on Reverse Merger That Hands Control to North Immunology - finance.biggo.com
Client and Medical Therapeutic Company Aethlon Medical Announces Merger With North Immunology - Procopio
Aethlon Medical To Merge With North Immunology And Raise $180 Million To Advance Atopic Dermatitis Drug NOR-101 - Pulse 2.0
North Immunology to go public via Aethlon reverse merger backed by USD 180m PIPE - AllSci
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
North Immunology joins biotech reverse merger boom with Aethlon deal - BioPharma Dive
Medical Tech Stock Aethlon Medical, Inc. (Nasdaq: AEMD) Soars on Merger News - Investorideas.com
AEMD Stock Soars 460% on the North Immunology Merger — But What Do Shareholders Actually Own? - TOP1markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruger & Company, Inc. (NYSE – RGR), Atkore, Inc. (NYSE – ATKR), Centerspace (NYSE – CSR), Aethlon Medical, Inc. (Nasdaq – AEMD) - Carroll County Mirror-Democrat
Aethlon Medical Jumps on North Immunology Merger and $180 Million Financing Plan - Quiver Quantitative
Aethlon Medical (AEMD) Stock Rockets 471% Following North Immunology Merger Announcement - Blockonomi
Remember to sell bro 😘 - Moomoo
Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboration with Roche, Aethlon Medical Merges with North Immunology - Pharmaceutical Executive
Aethlon’s 467% Stock Rally Reflects a $16.5 Million Merger Stub, Not a $346.5 Million Windfall - TechStock²
Trending Stocks Today | Aethlon Medical Soars 475.17% - moomoo.com
Aethlon Medical, North Immunology Plan Merger Backed by $180 Million Financing - citybiz
Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger - Yahoo Finance
Why Did Aethlon Medical Stock Jump 4X on Thursday?Aethlon Medical (NASDAQ:AEMD) - Benzinga
Aethlon Medical to Merge With North Immunology in All-Stock Deal Backed by $180 Million Financing - Minichart
AEMD Surges 346% Premarket on Merger News; Price-to-Sales Signals Market Skepticism - GuruFocus
North Immunology deal makes Aethlon (NASDAQ: AEMD) a minority owner - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
$180 million fuels Aethlon Medical (NASDAQ: AEMD) merger built around a new skin-disease antibody - Stock Titan
AEMD Stock Whipsaws As Traders Eye Conference Catalyst - timothysykes.com
Aethlon Medical stock soars over 400% on North Immunology merger deal - Investing.com
Aethlon Medical stock soars over 400% on North Immunology merger deal By Investing.com - Investing.com South Africa
Aethlon Medical (AEMD) Announces Merger with North Immunology, M - GuruFocus
The AI's pre-market trailing stop-loss is truly impressive - Moomoo
$Aethlon Medical (AEMD.US)$ i got fomo selling early so gotta give it another shot.. 😘😘 @Michael_11 - Moomoo
Aethlon Medical, Inc. (NASDAQ:AEMD) To Merge With North Immunology; $180M Financing - TradingView
Halper Sadeh probes Aethlon Medical merger for shareholder fairness - scanx.trade
Aethlon Medical (NASDAQ: AEMD) Revises Executive Severance Agreements to Enable One-Time Lump Sum Payments - kalkinemedia.com
Aethlon Medical amends executive agreements to change severance payment terms - Investing.com Australia
Form 8K Aethlon Medical Inc For: 15 September By Investing.com - Investing.com Nigeria
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):